Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients

Bjørn H Ebdrup, Martin C Axelsen, Nikolaj Bak, Birgitte Fagerlund, Bob Oranje, Jayachandra M Raghava, Mette Ø Nielsen, Egill Rostrup, Lars K Hansen, Birte Y Glenthøj, Bjørn H Ebdrup, Martin C Axelsen, Nikolaj Bak, Birgitte Fagerlund, Bob Oranje, Jayachandra M Raghava, Mette Ø Nielsen, Egill Rostrup, Lars K Hansen, Birte Y Glenthøj

Abstract

Background: A wealth of clinical studies have identified objective biomarkers, which separate schizophrenia patients from healthy controls on a group level, but current diagnostic systems solely include clinical symptoms. In this study, we investigate if machine learning algorithms on multimodal data can serve as a framework for clinical translation.

Methods: Forty-six antipsychotic-naïve, first-episode schizophrenia patients and 58 controls underwent neurocognitive tests, electrophysiology, and magnetic resonance imaging (MRI). Patients underwent clinical assessments before and after 6 weeks of antipsychotic monotherapy with amisulpride. Nine configurations of different supervised machine learning algorithms were applied to first estimate the unimodal diagnostic accuracy, and next to estimate the multimodal diagnostic accuracy. Finally, we explored the predictability of symptom remission.

Results: Cognitive data significantly classified patients from controls (accuracies = 60-69%; p values = 0.0001-0.009). Accuracies of electrophysiology, structural MRI, and diffusion tensor imaging did not exceed chance level. Multimodal analyses with cognition plus any combination of one or more of the remaining three modalities did not outperform cognition alone. None of the modalities predicted symptom remission.

Conclusions: In this multivariate and multimodal study in antipsychotic-naïve patients, only cognition significantly discriminated patients from controls, and no modality appeared to predict short-term symptom remission. Overall, these findings add to the increasing call for cognition to be included in the definition of schizophrenia. To bring about the full potential of machine learning algorithms in first-episode, antipsychotic-naïve schizophrenia patients, careful a priori variable selection based on independent data as well as inclusion of other modalities may be required.

Trial registration: ClinicalTrials.gov NCT01154829.

Keywords: Antipsychotic-naïve first-episode schizophrenia; cognition; diffusion tensor imaging; electrophysiology; machine learning; structural magnetic resonance imaging.

Figures

Fig. 1.
Fig. 1.
Diagram of the multivariate analysis pipeline. Forty-six patients and 58 healthy controls were included in the baseline analyses. ‘Data’ refer to input variables from cognition, electrophysiology, structural magnetic resonance imaging, and diffusion tensor imaging. For each of the 100 splits, 2/3 of subjects were used for training and 1/3 of subjects were used for testing. Subjects with missing data were not used in test sets. Training data were scaled (zero mean, unit variance), and the test sets were scaled using these parameters. Missing data were imputed using K-nearest neighbor imputation with K = 3 (Bak and Hansen, 2016), and only subjects with complete data were included in the test sets. Finally, nine different configurations of machine learning algorithms were applied to predict diagnosis. CV = cross-validation. See text for details.
Fig. 2.
Fig. 2.
Unimodal diagnostic accuracies for cognition (Cog), electrophysiology (EEG), structural magnetic resonance imaging (sMRI), and diffusion tensor imaging (DTI) for each of the nine different configurations of machine learning algorithms. X-axes show the accuracies (acc), and y-axes show the sum of correct classifications for each of the 100 random subsamples (see Fig. 1). Dotted vertical black line indicates chance accuracy (56%). With cognitive data, all nine configurations of algorithms significantly classified ‘patient v. control’ (p values = 0.001–0.009). No algorithms using EEG, sMRI, and DTI-data resulted in accuracies exceeding chance. The nine different configuration of machine learning algorithms: nB, naïve Bayes; LR, logistic regression without regularization; LR_r, logistic regression with regularization; SVM_l, support vector machine with linear kernel; SVM_h, SVM with heuristic parameters; SVM_o, SVM optimized through cross-validation; DT, decision tree; RF, random forest; AS, auto-sklearn. See text for details.
Fig. 3.
Fig. 3.
(a) Manhattan plot with univariate t tests of all variables along the x-axis [cognition (Cog), electrophysiology (EEG), structural magnetic resonance imaging (sMRI), and diffusion tensor imaging (DTI)] and log-transformed p values along the y-axis. Lower dashed horizontal line indicates significance level of p = 0.05. Upper dashed lines indicate the Bonferroni-corrected p value for each modality. (b) In colored horizontal lines, the fraction of data splits (see Fig. 1), where individual variables were included in the final machine learning model, which determined the diagnostic accuracy (presented in Fig. 2). Specification of variables is provided in online Supplementary Material. Only configurations of the six machine learning algorithms, which included feature selection, are shown. nB, naïve Bayes; LR, logistic regression without regularization; LR_r, logistic regression with regularization; SVM_l, support vector machine with linear kernel; DT, decision tree; RF, random forest.

References

    1. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC and Freedman R (1982) Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biological Psychiatry 17, 639–654.
    1. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR and Weinberger DR (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry 162, 441–449.
    1. Anhøj S, Ødegaard Nielsen M, Jensen MH, Ford K, Fagerlund B, Williamson P, Glenthøj B and Rostrup E (2018) Alterations of intrinsic connectivity networks in antipsychotic-naïve first-episode schizophrenia. Schizophrenia Bulletin 44, 1332–1340.
    1. Bak N and Hansen LK (2016) Data driven estimation of imputation error – a strategy for imputation with a reject option. Ed. Z Zhang. PLoS ONE 11, e0164464.
    1. Bak N, Ebdrup BHH, Oranje B, Fagerlund B, Jensen MHH, Düring SWW, Nielsen MØØ, Glenthøj BYY and Hansen LKK (2017) Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology. Translational Psychiatry 7, e1087.
    1. Benjamini Y and Hochberg Y (1995) Controlling the false discovery rate: a Practical and powerful approach to Multiple testing. Wiley Royal Statistical Society. Journal of the Royal Statistical Society. Series B (Methodological) 57, 289–300.
    1. Bishop CM (2006) Pattern Recognition and Machine Learning. New York, NY: Springer.
    1. Blakey R, Ranlund S, Zartaloudi E, Cahn W, Calafato S, Colizzi M, Crespo-Facorro B, Daniel C, Díez-Revuelta Á, Di Forti M, Iyegbe C, Jablensky A, Jones R, Hall M-H, Kahn R, Kalaydjieva L, Kravariti E, Lin K, McDonald C, McIntosh AM, Picchioni M, Powell J, Presman A, Rujescu D, Schulze K, Shaikh M, Thygesen JH, Toulopoulou T, Van Haren N, Van Os J, Walshe M, Murray RM, Bramon E and Bramon E (2018) Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains. Psychological Medicine 48, 1325–1340.
    1. Bora E and Pantelis C (2016) Social cognition in schizophrenia in comparison to bipolar disorder: a meta-analysis. Schizophrenia Research 175, 72–78.
    1. Braff DL and Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Archives of general Psychiatry 47, 181–188.
    1. Breiman L (2001) Random forests. Kluwer Academic Publishers Machine Learning 45, 5–32.
    1. Breiman L, Friedman J, Olshen R and Stone C (1984) Classification and Regression Trees. New York: Chapman and Hall, Wadsworth.
    1. Busner J and Targum SD (2007) The clinical global impressions scale: applying a research tool in clinical practice. Matrix Medical Communications Psychiatry (Edgmont (Pa.: Township)) 4, 28–37.
    1. Canu E, Agosta F and Filippi M (2015) A selective review of structural connectivity abnormalities of schizophrenic patients at different stages of the disease. Schizophrenia Research 161, 19–28.
    1. Castelvecchi D (2016) Can we open the black box of AI? Nature 538, 20–23.
    1. Cawley G and Talbot N (2010) On over-fitting in model selection and subsequent selection bias in performance evaluation. Journal of Machine Learning Research 11, 2079–2107.
    1. Chu W-L, Huang M-W, Jian B-L, Hsu C-Y and Cheng K-S (2016) A correlative classification study of schizophrenic patients with results of clinical evaluation and structural magnetic resonance images. Behavioural Neurology 2016, 1–11.
    1. Cortes C (1995). Support-Vector Networks. vol 20.
    1. Crespo-Facorro B, Roiz-Santiáñez R, Pelayo-Terán JM, González-Blanch C, Pérez-Iglesias R, Gutiérrez A, de Lucas EM, Tordesillas D and Vázquez-Barquero JL (2007) Caudate nucleus volume and its clinical and cognitive correlations in first episode schizophrenia. Schizophrenia Research 91, 87–96.
    1. Dazzan P (2014) Neuroimaging biomarkers to predict treatment response in schizophrenia: the end of 30 years of solitude? Dialogues in Clinical Neuroscience 16, 491–503.
    1. Düring S, Glenthøj BY, Andersen GS and Oranje B (2014) Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients. Neuropsychopharmacology 39, 3000–3008.
    1. Düring S, Glenthøj BY and Oranje B (2015) Effects of blocking D2/D3 receptors on mismatch negativity and P3a amplitude of initially antipsychotic naïve, first episode schizophrenia patients. The International Journal of Neuropsychopharmacology 19, pyv109.
    1. Ebdrup BH, Raghava JM, Nielsen MØ, Rostrup E and Glenthøj B (2016) Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade. Journal of Psychiatry & Neuroscience: JPN 41, 133–141.
    1. Feurer M, Klein A, Eggensperger K, Springenberg J, Blum M and Hutter F (2015) Efficient and Robust Automated Machine Learning 2962–2970.
    1. Fitzsimmons J, Kubicki M and Shenton ME (2013) Review of functional and anatomical brain connectivity findings in schizophrenia. Current Opinion in Psychiatry 26, 172–187.
    1. Gong Q, Lui S and Sweeney JA (2016) A selective review of cerebral abnormalities in patients with first-episode schizophrenia before and after treatment. The American Journal of Psychiatry 173, 232–243.
    1. Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ and Stone WS (2006) The consortium on the genetics of schizophrenia: neurocognitive endophenotypes. Schizophrenia Bulletin 33, 49–68.
    1. Haijma SV, Van Haren N, Cahn W, Koolschijn PCMP, Hulshoff Pol HE and Kahn RS (2013) Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophrenia Bulletin 39, 1129–1138.
    1. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Sanislow C and Wang P (2010) Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. American Journal of Psychiatry 167, 748–751.
    1. Jablensky A (2016) Psychiatric classifications: validity and utility. World Psychiatry 15, 26–31.
    1. Jenkinson M, Beckmann CF, Behrens TEJ, Woolrich MW and Smith SM (2012) FSL. NeuroImage 62, 782–790.
    1. Jessen K, Rostrup E, Mandl RCW, Nielsen MØ, Bak N, Fagerlund B, Glenthøj BY and Ebdrup BH (2018) Cortical structures and their clinical correlates in antipsychotic-naïve schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment. Psychological Medicine 8, 1–10.
    1. Kahn RS and Keefe RSE (2013). Schizophrenia is a cognitive illness: time for a change in focus. JAMA Psychiatry 70, 1107–1112.
    1. Kambeitz J, Kambeitz-Ilankovic L, Leucht S, Wood S, Davatzikos C, Malchow B, Falkai P and Koutsouleris N (2015). Detecting neuroimaging biomarkers for schizophrenia: a meta-analysis of multivariate pattern recognition studies. Neuropsychopharmacology 40, 1742–1751.
    1. Kapur S, Phillips AG and Insel TR (2012). Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Molecular Psychiatry 17, 1174–1179.
    1. Karageorgiou E, Schulz SC, Gollub RL, Andreasen NC, Ho B-C, Lauriello J, Calhoun VD, Bockholt HJ, Sponheim SR and Georgopoulos AP (2011) Neuropsychological testing and structural magnetic resonance imaging as diagnostic biomarkers early in the course of schizophrenia and related psychoses. Neuroinformatics 9, 321–333.
    1. Kay SR, Fiszbein A and Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261–276.
    1. Keefe RSE, Goldberg TE, Harvey PD, Gold JM, Poe MP and Coughenour L (2004) The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Research 68, 283–297.
    1. Koychev I, El-Deredy W, Mukherjee T, Haenschel C and Deakin JFW (2012) Core dysfunction in schizophrenia: electrophysiology trait biomarkers. Acta Psychiatrica Scandinavica 126, 59–71.
    1. Lowe CJ, Safati A and Hall PA (2017) The neurocognitive consequences of sleep restriction: a meta-analytic review. Neuroscience & Biobehavioral Reviews 80, 586–604.
    1. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV and Seidman LJ (2009). Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 23, 315–336.
    1. Nelson HE and O'Connell A (1978) Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex 14, 234–244.
    1. Neuhaus AH and Popescu FC (2018) Impact of sample size and matching on single-subject classification of schizophrenia: a meta-analysis. Schizophrenia Research 192, 479–480.
    1. Nielsen MO, Rostrup E, Wulff S, Bak N, Broberg BV, Lublin H, Kapur S and Glenthoj B (2012a) Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Archives of General Psychiatry 69, 1195–1204.
    1. Nielsen MØ, Rostrup E, Wulff S, Bak N, Lublin H, Kapur S and Glenthøj B (2012b) Alterations of the brain reward system in antipsychotic naïve schizophrenia patients. Biological Psychiatry 71, 898–905.
    1. Paulus MP, Rapaport MH and Braff DL (2001) Trait contributions of complex dysregulated behavioral organization in schizophrenic patients. Biological Psychiatry 49, 71–77.
    1. Pettersson-Yeo W, Benetti S, Marquand AF, Dell'Acqua F, Williams SCR, Allen P, Prata D, McGuire P and Mechelli A (2013) Using genetic, cognitive and multi-modal neuroimaging data to identify ultra-high-risk and first-episode psychosis at the individual level. Psychological Medicine 43, 2547–2562.
    1. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L and Rabbitt P (1994) Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia (Basel, Switzerland) 5, 266–281.
    1. Santos-Mayo L, San-Jose-Revuelta LM and Arribas JI (2017) A computer-aided diagnosis system with EEG based on the P3b wave during an auditory odd-ball task in schizophrenia. IEEE Transactions on Biomedical Engineering 64, 395–407.
    1. Shelley AM, Ward PB, Catts SV, Michie PT, Andrews S and McConaghy N (1991) Mismatch negativity: an index of a preattentive processing deficit in schizophrenia. Biological Psychiatry 30, 1059–1062.
    1. Shen C, Popescu FC, Hahn E, Ta TTM, Dettling M and Neuhaus AH (2014) Neurocognitive pattern analysis reveals classificatory hierarchy of attention deficits in schizophrenia. Oxford University Press Schizophrenia Bulletin 40, 878–885.
    1. Shepherd AM, Laurens KR, Matheson SL, Carr VJ and Green MJ (2012) Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neuroscience and Biobehavioral Reviews 36, 1342–1356.
    1. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM and Behrens TEJ (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 31, 1487–1505.
    1. Thibaut F, Boutros NN, Jarema M, Oranje B, Hasan A, Daskalakis ZJ, Wichniak A, Schmitt A, Riederer P and Falkai P, WFSBP Task Force on Biological Markers (2015) Consensus paper of the WFSBP Task Force on Biological Markers: criteria for biomarkers and endophenotypes of schizophrenia part I: neurophysiology. The World Journal of Biological Psychiatry 16, 280–290.
    1. Varoquaux G, Raamana PR, Engemann DA, Hoyos-Idrobo A, Schwartz Y and Thirion B (2017) Assessing and tuning brain decoders: cross-validation, caveats, and guidelines. NeuroImage 145, 166–179.
    1. Veronese E, Castellani U, Peruzzo D, Bellani M and Brambilla P (2013) Machine learning approaches: from theory to application in schizophrenia. Computational and Mathematical Methods in Medicine 2013, 867924.
    1. Wechsler Adult Intelligence Scale® – Third Edition (n.d.).
    1. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D and Sartorius N (1990) SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry 47, 589–593.
    1. Winterburn JL, Voineskos AN, Devenyi GA, Plitman E, de la Fuente-Sandoval C, Bhagwat N, Graff-Guerrero A, Knight J and Chakravarty MM (2017) Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study. Schizophrenia Research. doi: 10.1016/j.schres.2017.11.038.
    1. Wulff S, Pinborg LH, Svarer C, Jensen LT, Nielsen MØ, Allerup P, Bak N, Rasmussen H, Frandsen E, Rostrup E and Glenthøj BY (2015) Striatal D(2/3) binding potential values in drug-naïve first-episode schizophrenia patients correlate with treatment outcome. Schizophrenia Bulletin 41, 1143–1152.
    1. Xiao Y, Yan Z, Zhao Y, Tao B, Sun H, Li F, Yao L, Zhang W, Chandan S, Liu J, Gong Q, Sweeney JA and Lui S (2017) Support vector machine-based classification of first episode drug-naïve schizophrenia patients and healthy controls using structural MRI. Schizophrenia Research. doi: 10.1016/j.schres.2017.11.037.
    1. Zarogianni E, Storkey AJ, Johnstone EC, Owens DGC and Lawrie SM (2017) Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features. Schizophrenia Research 181, 6–12.

Source: PubMed

3
Tilaa